Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices

American Journal of Pathology

Volumn 154, Issue 6, 1999, Pages 1731-1742

  Kroon, Marielle E ^a   Koolwijk, Pieter ^a   Van Goor, Harry ^b   Weidle, Ulrich H ^e   Collen, Annemie ^a   Van Der Pluijm, Gabri ^c   Van Hinsbergh, Victor W M ^a,d  

^a TNO   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; UROKINASE RECEPTOR;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR BINDING; VASCULAR ENDOTHELIUM;

EID: 0033017205     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65429-6     Document Type: Article

References (59)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1995, 1:27-31
2. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
3. Battegay EJ: Angiogenesis: mechanistic insights, neovascular diseases and therapeutic prospects. J Mol Med 1995, 73:333-346
4. Isner JM: Angiogenesis for revascularization of ischemic tissues. Eur Heart J 1997, 18:1-2
5. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM: Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994, 145:883-894
6. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 1986, 46:467-473
7. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD: Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993, 122:673-684
8. Bacarach E, Itin A, Keshet E: In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 1992, 89: 10686-10690
9. Moscatelli D, Rifkin DB: Membrane and matrix localization of proteases: a common theme in tumor invasion and angiogenesis. Biochim Biophys Acta 1988, 948:67-85
10. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloprotease MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85:683-693
11. Yebra M, Parry GCN, Stromblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA: Requirement of receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration. J Biol Chem 1996, 271:29393-29399
12. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM: Fibrin containing gels induce angiogenesis: implications for stroma generation and wound healing. Lab Invest 1987, 57:673-686
13. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD: Transforming growth factor-β1 modulates basic fibroblast growth factor-induced proteolitic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990, 111:743-755
14. Koolwijk P, Erck van M, de Vree W, Vermeer MA, Weich HA, Hanemaaijer R, van Hinsbergh VWM: Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix: role of urokinase activity. J Cell Biol 1996, 132:1177-1188
15. Pepper MS, Ferrara L, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992, 189:824-831
16. Van Hinsbergh VWM, van den Berg EA, Fiers W, Dooijewaard G: Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990, 10:1991-1998
17. Mignatti P, Mazzieri R, Rifkin DB: Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 1991, 113:1193-1201
18. Ploug M, Rønne E, Berhendt N, Jensen AL, Blasi F, Danø KL: Cellular receptor for urokinase plasminogen activator: carboxy terminal processes and membrane anchoring. J Biol Chem 1991, 266:1926-1933
19. Quax PHA, Pederson N. Masucci MT, Weening-Verhoeff EJ, Danø K, Verheijen JH, Blasi F: Complementation between urokinase-producing and receptor-producing cells in extracellular-matrix degradation. Cell Regul 1991, 2:793-803
20. Xu Y, Hagege J, Doublet JD, Callard P, Sraer JD, Ronne E, Rondeau E: Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma. Hum Pathol 1997, 28:206-213
21. Min HY, Doyle LV, Vitt CR, Zandonella CL, Stratton-Thomas JR, Shuman MA, Rosenberg S: Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res 1996, 56:2428-2433
22. Evans CP, Elfman F, Parangi S, Conn M, Cunha G, Shurnan MA: Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade. Cancer Res 1997, 57:3594-3599
23. Loskutoff DJ: Regulation of PAI-1 gene expression Fibrinolysis 1991, 5:197-206
24. Ellis V, Behrendt N, Danø K: Plasminogen activation by receptor bound urokinase: a kinetic study with both cell-associated and isolated receptor. J Biol Chem 1991, 266:12752-12758
25. Nykjær A, Conese M, Christensen EI, Olson D, Cremona O, Gliemann J, Blasi F: Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J 1997, 16:2610-2620
26. Andreasen PA, Sottrup-Jensen L, Kjøller L, Nykjær A, Moestrup SK, Petersen CM, Gliemann J: Receptor mediated endocytosis of plasminogen activators and activor/inhibitor complexes. FEBS Lett 1994, 338:239-245
27. Heegaard CW, Simonsen ACW, Oka K, Kjøller L, Christensen A, Madsen B, Ellgaard L, Chan L, Andreasen PA: Very low density lipoprotein receptor binds and mediates endocytosis of uroknase-type plasminogen activator-type-1 plasminogen activator inhibitor complex J Biol Chem 1995, 270:20855-20861
28. Argraves KM, Battey FD. MacCalmans CD, McCrae KR, Gålvels M, Kozarsky KF, Chappell DA, Straus JF, Strickland DK: The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes J Biol Chem 1995, 270:26550-26557
29. Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, Ruggiero M: Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun 1993, 2:347-352
30. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L: Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 1994, 126:259-270
31. Dumler I, Weis A, Mayboroda OA, Maasch C. Jerke U, Haller H, Gulba DC: The JAK/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 1998, 273:315-321
32. Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE: The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 1998, 273: 18268-18272
33. Wei Y, Waltz DA, Rao N. Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994, 269:32380-32388
34. Rao NK, Shi GP, Chapman HA: Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression. J Clin Invest 1995, 96:465-474
35. Maciag T, Cerundolo J, Ilsley PR, Fornad R: An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979, 76:5674-5678
36. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK: Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 1988, 7:4119-27
37. Wijgaards G, Kluft C, Groeneveld E: Demonstration of urokinase-related fibrinolytic activity in human plasma. Br J Haemotol 1982, 51:165
38. Bohuslav J, Horejsí V, Hansmann C, Stöckl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H: Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995, 181:1381-1390
39. Defilippi P, van Hinsbergh VWM. Bertolotto A, Rossino P, Silengo L, Tarone G: Differential distribution and modulation of expression of α1/β1 integrin on human endothelial cells. J Cell Biol 1991, 114:855-863
40. Van Hinsbergh VWM, Sprengers ED, Kooistra EA: Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 1987, 57:148-153
41. van der Pluijm G, Vloedgraven HJM, Ivanov B, Robey FA, Grzesik WJ, Robey PG, Papapoulos SE, Löwik CWGM: Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res 1996, 56:1948-1955
42. Binnema DJ. Dooijewaard G, Turion PN: An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Thromb Haemost 1991, 12:144-148
43. Yasunaga C, Nakashima Y, Sueishi K: A role of fibrinolytic activity in angiogenesis. Lab Invest 1989, 61:698-704
44. Lansink M, Koolwijk P, van Hinsbergh V, Kooistra T: Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood 1998, 92:927-938
45. Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M: Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotide against the urokinase receptor. Lab Invest 1998, 78:1109-1119
46. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA: Regulation of integrin function by the urokinase receptor. Science 1996, 273:1551-1555
47. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT: The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 1996, 224:344-353
48. Waltz DA, Natkin LR, Fujita RM, Wei Y, Chapman HA: Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest 1997, 100:58-67
49. Chang AW, Kuo A, Barnathan ES, Okada SS: Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase. Arterioscler Thromb Vasc Biol 1998, 18:1855-1860
50. Preissner KT, Jenne D: Vitronectin: a new molecular connection in haemostasis. Thromb Haemost 1991, 66:189-194
51. Chang MC. Wang BR, Huang TF: Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibitor by Arg-Gly-Asp-containing peptides. Thromb Haemost 1995, 74:764-769
52. Thiagarajan P, Rippon AJ, Farrel DH: Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochemistry 1996, 35:4169-4175
53. Francis CW, Bunce LA, Sporn LA: Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain. Blood Cells 1993, 19:291-306
54. Stephens RW, Pallänen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Rønne E, Saksela O, Moscatelli D, Rifkin DB: Activation of prourokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 1989, 108:1987-1995
55. Wagner SN, Atkinson MJ, Wagner C, Hofler H, Schmitt M, Wilhelm O: Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal kidney. Histochem Cell Biol 1996, 105:53-60
56. Christofidou-Solomidou MC, Bridges M, Murphy GF, Albelda SM, DeLisser HM: Expression and function of endothelial cell αV integrin receptors in wound-induced human angiogenesis in human skin/ SCID mice chimeras. Am J Pathol 1990, 151:975-983
57. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatterman, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275: 964-967
58. Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES: Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1432-1443
59. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1995, 13:1444-1455